Patents by Inventor Joel Trugman

Joel Trugman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating migraine
    Patent number: 12350259
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: July 8, 2025
    Assignee: Allergan Pharmaceuticals International Limited
    Inventors: Ramesh Boinpally, Joel Trugman
  • METHODS OF TREATING MIGRAINE
    Publication number: 20250186412
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 18, 2025
    Publication date: June 12, 2025
    Inventors: Ramesh Boinpally, Joel Trugman
  • METHODS OF TREATING MIGRAINE
    Publication number: 20250186413
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 18, 2025
    Publication date: June 12, 2025
    Inventors: Ramesh Boinpally, Joel Trugman
  • METHODS OF TREATING MIGRAINE
    Publication number: 20250032466
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 11, 2024
    Publication date: January 30, 2025
    Inventors: Ramesh Boinpally, Joel Trugman
  • METHODS OF TREATING MIGRAINE
    Publication number: 20250032467
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 11, 2024
    Publication date: January 30, 2025
    Inventors: Ramesh Boinpally, Joel Trugman
  • Treatment of migraine
    Patent number: 12090148
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: September 17, 2024
    Assignee: Allergan Pharmaceuticals International Limited
    Inventors: Joel Trugman, Michelle Finnegan
  • PREVENTIVE TREATMENT OF MIGRAINE
    Publication number: 20230321055
    Abstract: The present disclosure provides medicaments and methods for the preventive treatment of migraine, particularly the preventive or prophylactic treatment of chronic migraine.
    Type: Application
    Filed: March 9, 2023
    Publication date: October 12, 2023
    Inventors: Joel Trugman, Michelle Finnegan
  • Treatment of migraine
    Patent number: 11717515
    Abstract: The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and/or P-gp only inhibitors.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: August 8, 2023
    Assignee: Allergan Pharmaceuticals International Limited
    Inventors: Joel Trugman, Ramesh Boinpally, Abhijeet Jakate, Michelle Finnegan
  • METHODS OF TREATING MIGRAINE
    Publication number: 20230130736
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 27, 2022
    Publication date: April 27, 2023
    Inventors: Ramesh Boinpally, Joel Trugman
  • TREATMENT OF MIGRAINE
    Publication number: 20220193051
    Abstract: The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and/or P-gp only inhibitors.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 23, 2022
    Inventors: Joel Trugman, Ramesh Boinpally, Abhijeet Jakate, Michelle Finnegan
  • Treatment of Migraine
    Publication number: 20220031686
    Abstract: The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Inventors: Joel Trugman, Michelle Finnegan
  • TREATMENT OF MIGRAINE
    Publication number: 20210379029
    Abstract: The application provides methods for the treatment of migraine for patients that are poor responders to triptan treatments. Some embodiments provide methods for treating or reducing migraine in patients that do not adequately respond to triptan treatments comprising the step of administering an effective amount of CGRP antagonists; for example, ubrogepant or atogepant, or a pharmaceutically acceptable salt, ester or prodrug thereof.
    Type: Application
    Filed: August 19, 2021
    Publication date: December 9, 2021
    Inventors: Joel Trugman, Michelle Finnegan
  • TREATMENT OF MIGRAINE
    Publication number: 20190374520
    Abstract: The application provides prophylactic methods for the treatment of migraine by the administration of a CGRP antagonist, preferably atogepant or ubrogepant, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 6, 2019
    Publication date: December 12, 2019
    Inventors: Joel Trugman, Michelle Finnegan
  • TREATMENT OF MIGRAINE
    Publication number: 20190374518
    Abstract: The application provides methods for the treatment of migraine for patients that are poor responders to triptan treatments. Some embodiments provide methods for treating or reducing migraine in patients that do not adequately respond to triptan treatments comprising the step of administering an effective amount of CGRP antagonists; for example, ubrogepant or atogepant, or a pharmaceutically acceptable salt, ester or prodrug thereof.
    Type: Application
    Filed: June 6, 2019
    Publication date: December 12, 2019
    Inventors: Joel Trugman, Michelle Finnegan